Your browser doesn't support javascript.
loading
Advances in SEMA3F regulation of clinically high-incidence cancers.
Wang, Chaofeng; Song, Dezhi; Huang, Qian; Liu, Qian.
Afiliación
  • Wang C; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Song D; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.
  • Huang Q; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Liu Q; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi, China.
Cancer Biomark ; 38(2): 131-142, 2023.
Article en En | MEDLINE | ID: mdl-37599522

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias Colorrectales / Carcinoma Hepatocelular / Neoplasias de Cabeza y Cuello / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Biomark Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas / Neoplasias Colorrectales / Carcinoma Hepatocelular / Neoplasias de Cabeza y Cuello / Neoplasias Hepáticas Tipo de estudio: Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Biomark Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos